Clearwater, Florida (PRWEB) June 24, 2013
The interview of Mr. Dwight Brunoehler CEO of Biostem U.S. Corporation (HAIR) receives 234,000 views in 1 week. People with hair loss enjoyed watching this informative video interview.
Biostem U.S. is a public company trading on the over the counter market under the ticker symbol HAIR.ob.
In this video video interview Mr. Dwight Brunoehler talks about hair loss industry. Hair loss industry is a $2 Billion annual market where HAIR provides much needed services. Mr. Dwight Brunoehler also talks about how Biostem has completely avoided any controversy in the use of stem cells in its Regenerative medicine therapies. From the interview we also learn how acquisitions play into HAIR.ob's future growth plans and why the Company believes they could soon be acquired by a highly-motivated investment fund.
About Biostem U.S., Corporation:
Biostem U.S., Corporation (OTCQB: HAIR) is a fully reporting Nevada corporation with offices in Clearwater, Florida. Biostem U.S. is a technology licensing company with proprietary technology centered on providing hair re-growth using human stem cells. The company also intends to train and license selected physicians to provide Regenerative Cellular Therapy treatments to assist the body's natural approach to healing tendons, ligaments, joints and muscle injuries by using the patient's own stem cells. Biostem U.S. is seeking to expand its operations worldwide through licensing of its proprietary technology and acquisition of existing stem cell related facilities. The company's goal is to operate in the international biotech market, focusing on the rapidly growing regenerative medicine field, using ethically sourced adult stem cells to improve the quality and longevity of life for all mankind.
Read the full story at http://www.prweb.com/releases/2013/6/prweb10852046.htm.
Copyright©2012 Vocus, Inc.
All rights reserved